N-(4-((6-(4-(Dimethylamino)phenyl)-2-isopropyl-3H-imidazo[4,5-b]pyridin-7-yl)oxy)-3-fluorophenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

ID: ALA4279522

PubChem CID: 145980977

Max Phase: Preclinical

Molecular Formula: C35H30F2N6O3

Molecular Weight: 620.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1

Standard InChI:  InChI=1S/C35H30F2N6O3/c1-20(2)32-40-30-31(27(19-38-33(30)41-32)21-7-12-24(13-8-21)42(3)4)46-29-16-11-23(18-28(29)37)39-34(44)26-6-5-17-43(35(26)45)25-14-9-22(36)10-15-25/h5-20H,1-4H3,(H,39,44)(H,38,40,41)

Standard InChI Key:  OCLRISHYEZJABI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
    4.7903  -13.3877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7891  -14.2152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5040  -14.6280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5022  -12.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2176  -13.3841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2224  -14.2106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0100  -14.4614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4919  -13.7899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0021  -13.1242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4998  -12.1500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2130  -11.7353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9266  -12.1481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6394  -11.7341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6374  -10.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9166  -10.4981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2068  -10.9143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4894  -10.5070    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.3500  -10.4926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0663  -10.9021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7790  -10.4865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0699  -11.7271    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4924  -10.8971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2047  -10.4821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2016   -9.6563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4802   -9.2470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7710   -9.6643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4947  -11.7221    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9207  -10.8919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9215  -11.7180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6367  -12.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3506  -11.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3448  -10.8832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6290  -10.4772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0672  -12.1212    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.0758  -12.9754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3169  -13.7851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7336  -14.4971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0790  -12.1495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3652  -11.7372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6498  -12.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6528  -12.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3670  -13.3877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9348  -11.7386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9334  -10.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2209  -12.1522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7252  -13.0682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 14 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 20  2  0
 22 27  2  0
 23 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 31 34  1  0
  1 35  1  0
  8 36  1  0
 36 37  1  0
 35 38  2  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 35  1  0
 40 43  1  0
 43 44  1  0
 43 45  1  0
 36 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4279522

    ---

Associated Targets(Human)

TYRO3 Tchem Tyrosine-protein kinase receptor TYRO3 (2906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AXL Tchem Tyrosine-protein kinase receptor UFO (3469 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MERTK Tchem Proto-oncogene tyrosine-protein kinase MER (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 620.66Molecular Weight (Monoisotopic): 620.2347AlogP: 7.29#Rotatable Bonds: 8
Polar Surface Area: 105.14Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.91CX Basic pKa: 4.48CX LogP: 6.26CX LogD: 6.26
Aromatic Rings: 6Heavy Atoms: 46QED Weighted: 0.19Np Likeness Score: -1.49

References

1. Baladi T, Aziz J, Dufour F, Abet V, Stoven V, Radvanyi F, Poyer F, Wu TD, Guerquin-Kern JL, Bernard-Pierrot I, Garrido SM, Piguel S..  (2018)  Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors.,  26  (20): [PMID:30309671] [10.1016/j.bmc.2018.09.031]

Source